‘Most Significant’ Eye Care Innovation…
‘Most Significant’ Eye Care Innovation…
The AdaptDx Pro may look like a pair of virtual reality goggles, but it’s really a device used for catching the early warning signs of age-related macular degeneration (AMD).
Read ArticleTurning Losses Into Gains
Leslie Gallagher, OD, FAAO, of Holton, Kansas discusses how a confirmed diagnosis of early or subclinical AMD provides her with the opportunity to discuss optical and nutraceutical needs, which benefit the patient and leads to additional revenue.
Read ArticleWhat Can We Do for AMD?
Ian Cameron, independent prescribing optometrist in Edinburgh, UK, explains why patients with early AMD deserve more attention and what can be done to help them.
Read ArticleShift Focus to Must-see Patients
Even amid COVID-19 worries, caring for patients with retinal disease is a necessity. Optometry needs to focus on essential office visits moving forward, including patients with macular disease.
Read ArticleQuarterbacking Retinal Disease
Paul Karpecki OD, FAAO, explains that with the right technology and the right team, optometrists can be confident when taking the next step—early diagnosis.
Read ArticleMPR and MacuLogix Received A’Design Award
MPR and MacuLogix were recognized with the A’Design Platinum Award, the world’s largest design competition, for its work on the AdaptDx Pro, a medical headset by MacuLogix.
Read ArticleElevate Standard of Care with Artificial Intelligence
As artificial intelligence becomes more common in screening, diagnosing, and treating eye conditions, it is revolutionizing the optometric industry.
Read ArticleOphthalmic Equipment Manufacturers Remain (Cautiously) Optimistic During the Pandemic
Ophthalmology too will return to some form of normal again, but it will be a new normal. As countries and citizens begin to realize post-pandemic life will be different, so too must ophthalmologists.
Read ArticleKnowledge Center: Age-Related Macular Degeneration
The AdaptDx Pro is truly a revolutionary way to quickly and effectively measure dark adaptation (to help detect subclinical AMD) in virtually any setting, without taking up too much staff or doctor time.
Read ArticleTheia Overcomes AMD Standard Of Care Challenges
“Open yourself up to learning something new. Education truly is the key to being a trailblazer,” says Frances Bynum, OD in her latest piece dedicated to conquering the challenges ODs face with subclinical AMD detection.
Read Article